Sergio Cortelazzo
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Journal: Blood advances
Published: December 07, 2022
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term.
Journal: Bone marrow transplantation
Published: February 07, 2021
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
Journal: British journal of haematology
Published: February 04, 2021
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Journal: Hematological oncology
Published: December 01, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07.
Journal: Blood cancer journal
Published: August 19, 2020
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial.
Journal: The Lancet. Haematology
Published: August 13, 2020
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Journal: Hematological oncology
Published: June 26, 2020
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes.
Journal: JCO clinical cancer informatics
Published: October 22, 2019
Last Updated: 09/26/2026